The company’s year-end revenue of $368.5 million was up 3.8 percent from 2011’s $354.9 million.
Total product sales helped boost the minimally invasive device company’s bottom line, as sports medicine and ENT sales both improved in the fourth quarter and from 2011. Fourth quarter sports medicine sales increased by 1.9 percent to $63.6 million, and ENT sales increased by 10.6 percent to $26.1 million.
Overall sales were up 3.7 percent for the year, from $338.3 million in 2011 to $350.7 million in 2012.
More Articles on Supply Chain:
ApiFix Receives CE Mark for Scoliosis Treatment Device
5 Recent Spine-Focused Device Company Financial Reports
Mazor Robotics Named 4th Most Innovative Robotics Company for Spine System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
